In vitro transdermal permeation of lidocaine-dodecanol binary eutectic system

Yaoxue Xuebao

Volumn 40, Issue 8, 2005, Pages 764-768

  Ke, Guang Ming ^a   Wang, Li ^b   Wang, Ping ^a   Lü, Wan Liang ^c   Wang, Shu Ming ^b   Zhang, Qiang ^c   Guo, Hong You ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b Development Ltd   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Lidocaine dodecanol binary eutectic system; Steady state transdermal flux; Thermodynamic activity; Transdermal delivery

Indexed keywords

LAURYL ALCOHOL; LIDOCAINE; LOCAL ANESTHETIC AGENT;

ANIMAL; ARTICLE; CHEMISTRY; DRUG COMBINATION; DRUG STABILITY; GUINEA PIG; INTRADERMAL DRUG ADMINISTRATION; SKIN ABSORPTION; SOLUBILITY;

ADMINISTRATION, CUTANEOUS; ANESTHETICS, LOCAL; ANIMALS; DODECANOL; DRUG COMBINATIONS; DRUG STABILITY; GUINEA PIGS; LIDOCAINE; SKIN ABSORPTION; SOLUBILITY;

EID: 26844499550     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Wang CX, Liu YL. New development of transdermal drug delivery system [J]. Acta Pharm Sin, 2002, 37(12):999-1002.
2. Blank IH. Cutaneous barrier [J]. J Invest Dermatol, 1965, 45(2):249-256.
3. Potts RO, Guy RH. A predicative algorithm for skin permeability: the effects of molecular size and hydrogen bond activity [J]. Pharm Res, 1995, 12(11):1628-1633.
4. Kasting GB, Smith RL, Cooper ER. Effects of lipid solubility and molecular size on percutaneous absorption [J]. Pharmacol Skin, 1987, 1(4):138-153.
5. Touitou E, Chow DD, Lawter JR. Chiral β-blockers for transdermal delivery [J]. Int J Pharm, 1994, 104(2):19-28.
6. Fleischer AB, Ford PG. How to minimize adverse effects of topical anesthetics [J]. Skin Aging, 1998, 6(3):54-61.
7. Litman SJ, Vitkun SA, Poppers PJ. Use of EMLA cream in the treatment of post-herpetic neuralgia [J]. J Clin Anesth, 1996, 8(1):54-57.
8. Jakobson B, Nilsson A. Methemoglobinemia associated with a prilocaine lidocaine cream and trimetoprimsulphamethoxazole. A case report [J]. Acta Anaesthesiol Scand, 1985, 29(4):453-455.
9. Kang L, Jun HW, McCall JW. Physicochemical studies of lidocaine-menthol binary systems for enhanced membrane transport [J]. Int J Pharm, 2000, 206(1-2):35-42.
10. Kang L, Jun HW, Mani N. Preparation and characterization of two-phase melt systems of lidocaine [J]. Int J Pharm, 2001, 222(1):35-44.
11. Nakana NI. Temperature-dependent solubilities of lidocaine, mepivacaine and bupivacaine [J]. J Pharm Sci, 1979, 68(5):667-668.
12. Valenta C, Siman U, Kratzel M, et al. The dermal delivery of lignocaine: influence of ion pairing [J]. Int J Pharm, 2000, 197(1-2):77-85.
13. Kushla GP, Zatz JL. Influence of pH on lidocaine penetration through human and hairless mouse skin in vitro [J]. Int J Pharm, 1991, 71(7):167-173.
14. Tanojo H, Boelsma E, Junginger HE, et al. In vivo human skin barrier modulation by topical application of fatty acids [J]. Skin Pharmacol Appl Skin Physiol, 1998, 11(6):87-97.
15. Aungst B, Rogers N, Shefter E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides [J]. Int J Pharm, 1986, 33(1-3):225-234.
16. Meylon WM, Howard PH. Atom/fragment contribution method for estimating octanol-water partition coefficients [J]. J Pharm Sci, 1995, 84(1):83-92.